Edwards Lifesciences
604 hedge funds and large institutions have $16.9B invested in Edwards Lifesciences in 2015 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 173 increasing their positions, 246 reducing their positions, and 46 closing their positions.
93% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 46
80% more call options, than puts
Call options by funds: $89.6M | Put options by funds: $49.8M
16% more capital invested
Capital invested by funds: $14.6B → $16.9B (+$2.31B)
6% more funds holding
Funds holding: 568 → 604 (+36)
11% less funds holding in top 10
Funds holding in top 10: 18 → 16 (-2)
30% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 246
237.88% less ownership
Funds ownership: 492.61% → 254.73% (-238%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$716M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$645M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$298M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$91.4M |
| 5 |
Two Sigma Investments
New York
|
+$61.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$311M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$139M |
| 3 |
Millennium Management
New York
|
-$135M |
| 4 |
HM
HealthCor Management
New York
|
-$113M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$85.6M |
EW Hedge Fund Activity: Q4 2015 in Review
604 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q4 2015, worth a combined $16.9B — up 16% from $14.6B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new EW positions and 46 closed out — a net gain of 43 holders — while 173 added to existing stakes and 246 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $716M. The largest seller was Citadel Advisors, cutting an estimated $311M.
- 604 institutional investors held Edwards Lifesciences (EW) as of Q4 2015, up from 568 in Q3 2015.
- Funds reported $16.9B of Edwards Lifesciences stock for Q4 2015, up 16% quarter-over-quarter.
- 89 funds opened new Edwards Lifesciences positions in Q4 2015 and 46 closed out, a net change of +43 holders.
- The largest Edwards Lifesciences buyer in Q4 2015 was State Street, an estimated $716M added.
- The largest Edwards Lifesciences seller in Q4 2015 was Citadel Advisors, an estimated $311M sold.
Based on aggregated 13F filings for Q4 2015.